| HOME >> BIOLOGY >> TECHNOLOGY |
Retained earnings 17,650,624 14,008,587
Accumulated other comprehensive
income 4,194,619 2,122,795
Total shareholders' equity 37,012,858 30,884,183
Total liabilities and
shareholders' equity $38,422,201 $32,640,238
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2008 AND 2007
(Unaudited)
2008 2007
CASH FLOWS FROM OPERATING
ACTIVITIES:
Net income $3,642,037 $1,890,855
Adjustments to reconcile net income
to cash used in operating activities:
Minority interest (45,310) (52,117)
Depreciation and amortization 193,572 130,330
Bad debt expense -- 876
Stock issued for services -- 134,550
Amortization of stock option and
warrant compensation 52,314 50,258
Amortization of deferred expenses 175,421 --
Loss on currency exchange -- 19,620
Change in operating assets
Accounts receivable, trade (657,089) 521,256
Notes receivables (1,670,875) --
Inventories (804,759) (2,500,265)
Advances to suppliers (3,473,818) (3,356,149)
Other current assets
'/>"/>
| SOURCE China Medicine Corporation Copyright©2008 PR Newswire. All rights reserved |